HomepageEarnings Events Newsdesk 3 days ago Apogee Enterprises, Inc (APOG) Q4 2026 Earnings Results Apogee Enterprises, Inc (NASDAQ: APOG) Q4 2026 Earnings Release Arrowhead Pharmaceuticals, Inc (ARWR) Arrowhead Pharmaceuticals Receives Positive CHMP Opinion Recommending Approval of REDEMPLO® (plozasiran) to Reduce Triglycerides in Adults with Familial Chylomicronemia Syndrome (FCS) in Europe » « Haemonetics Corp (HAE) New Study Highlights Safety and Efficacy Profile of Haemonetics' VASCADE MVP® XL in Large-Bore Venous Access Closure Procedures Newsdesk:
